Physician profile
David Scott Fligge
NPI 1184777658
$1,091.94
in general payments reported to CMS, 2019-2025
12 companies · $87.25 in 2025
The $87.25 reported for 2025 was more than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $503 · 2020: $38.74 · 2021: $25.00 · 2022: $25.96 · 2023: $308 · 2024: $104 · 2025: $87.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $482 · Honoraria: $17.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $481.72 |
| Honoraria | $17.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $676.34 | 2019-2024 | Endo Activator, Astra Tech Implant System, Midwest Stylus Plus |
| Patterson Companies, INC. | $140.28 | 2023-2025 | |
| Dental Imaging Technologies Corp. | $76.54 | 2019 | |
| Gc America INC. | $67.78 | 2022-2025 | Equia, G-Cem |
| Straumann USA LLC | $25.00 | 2021 | |
| Voco America INC. | $21.26 | 2019-2023 | Admira Fusion, Voco Profluorid Varnish, Futurabond U |
| Keystone Dental INC. | $17.68 | 2019 | |
| Benco Dental Supply Co. | $17.19 | 2025 | |
| Envista Holdings Corporation | $15.11 | 2024 | Nx3 |
| Ivoclar Vivadent, INC. | $14.36 | 2020 | |
| Align Technology, INC. | $12.91 | 2020 | |
| Ultradent Products INC | $7.49 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Fligge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.